Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 6 minute read Pharma Industry News Zervimesine development highlights regulatory complexity in dementia with Lewy bodies Zervimesine moves closer to Phase 2b as Cognition Therapeutics engages FDA. Read how regulatory complexity is shaping dementia drug development. bySoujanya RaviJanuary 30, 2026